Definitely not a sure thing, but we've all seen the results from the phase 2 studies and they definitely look impressive. I know people with this disease and they all seem incredibly excited about this treatment.
The EV is only $600m, yet it generates massive profits from its current revenues which represents only a minuscule fraction of the total potential addressable market for this company. That's why I'm invested. People without patience sold so that those with patience could buy at ridiculously cheap prices (ie the classic "money moving from the impatient to the patient).
Definitely not a sure thing, but we've all seen the results...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.37 |
Change
0.180(1.36%) |
Mkt cap ! $669.5M | |||
| Open | High | Low | Value | Volume |
| $13.19 | $13.59 | $13.13 | $1.181M | 88.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 606 | $13.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.51 | 282 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |